Expression of Serum Cytokines Profile in Neonatal Sepsis

References

• Shane AL, Sanchez PJ, Stoll BJ. Neonatal sepsis. Lancet. 2017;390(10104):1770–1780. doi:10.1016/S0140-6736(17)31002-4
   PubMed Web of Science ®Google Scholar
• Popescu CR, Cavanagh MMM, Tembo B, et al. Neonatal sepsis in low-income countries: epidemiology, diagnosis and prevention. Expert Rev Anti Infect Ther. 2020;18(5):443–452. doi:10.1080/14787210.2020.1732818
   PubMed Web of Science ®Google Scholar
• Heron M. Deaths: leading Causes for 2017. Natl Vital Stat Rep. 2019;68(6):1–77.
   PubMedGoogle Scholar
• Moni SC, Mollah AH, Banerjee M, Khan TH, Sejuti A, Morshed SS. Neonatal sepsis: clinical characteristics, epidemiology and antibiotic sensitivity pattern of the bacterial pathogens in neonatal intensive care unit of a tertiary care hospital. Mymensingh Med J. 2020;29(2):366–375.
   Google Scholar
• Carty M, Guy C, Bowie AG. Detection of viral infections by innate immunity. Biochem Pharmacol. 2021;183:114316. doi:10.1016/j.bcp.2020.114316
   PubMed Web of Science ®Google Scholar
• Kogut MH, Lee A, Santin E. Microbiome and pathogen interaction with the immune system. Poult Sci. 2020;99(4):1906–1913. doi:10.1016/j.psj.2019.12.011
   PubMed Web of Science ®Google Scholar
• Kumar V. Toll-like receptors in sepsis-associated cytokine storm and their endogenous negative regulators as future immunomodulatory targets. Int Immunopharmacol. 2020;89(Pt B):107087. doi:10.1016/j.intimp.2020.107087
   PubMed Web of Science ®Google Scholar
• Kurt AN, Aygun AD, Godekmerdan A, Kurt A, Dogan Y, Yilmaz E. Serum IL-1beta, IL-6, IL-8, and TNF-alpha levels in early diagnosis and management of neonatal sepsis. Mediators Inflamm. 2007;2007:31397. doi:10.1155/2007/31397
   PubMed Web of Science ®Google Scholar
• Leal YA, Álvarez-Nemegyei J, Lavadores-May AI, Girón-Carrillo JL, Cedillo-Rivera R, Velazquez JR. Cytokine profile as diagnostic and prognostic factor in neonatal sepsis. J Matern Fetal Neonatal Med. 2019;32(17):2830–2836. doi:10.1080/14767058.2018.1449828
   PubMed Web of Science ®Google Scholar
• Wu YQ, Shen J, Zhou QL, Zhao HW, Liu LR, Liu X. Interleukin-6 and interleukin-8 in diagnosing neonatal septicemia. J Biol Regul Homeost Agents. 2016;30(4):1107–1113.
   Web of Science ®Google Scholar
• Badr HS, El-Gendy FM, Helwa MA. Serum stromal-derived-factor-1 (CXCL12) and its alpha chemokine receptor (CXCR4) as biomarkers in neonatal sepsis. J Matern Fetal Neonatal Med. 2018;31(16):2209–2215. doi:10.1080/14767058.2017.1336760
   PubMed Web of Science ®Google Scholar
• Tunc T, Cekmez F, Cetinkaya M, et al. Diagnostic value of elevated CXCR4 and CXCL12 in neonatal sepsis. J Matern Fetal Neonatal Med. 2015;28(3):356–361. doi:10.3109/14767058.2014.916683
   PubMed Web of Science ®Google Scholar
• Cuenca AG, Wynn JL, Kelly-Scumpia KM, et al. Critical role for CXC ligand 10/CXC receptor 3 signaling in the murine neonatal response to sepsis. Infect Immun. 2011;79(7):2746–2754. doi:10.1128/IAI.01291-10
   Web of Science ®Google Scholar
• Goldstein B, Giroir B, Randolph A. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med. 2005;6(1):2–8. doi:10.1097/01.PCC.0000149131.72248.E6
   PubMedGoogle Scholar
• Dong Y, Basmaci R, Titomanlio L, Sun B, Mercier JC. Neonatal sepsis: within and beyond China. Chin Med J. 2020;133(18):2219–2228. doi:10.1097/CM9.0000000000000935
   PubMed Web of Science ®Google Scholar
• Machado JR, Soave DF, da Silva MV, de Menezes LB, Etchebehere RM, Monteiro ML. dos Reis MA, Correa RR, Celes MR: neonatal sepsis and inflammatory mediators. Mediators Inflamm. 2014;2014:269681. doi:10.1155/2014/269681
   PubMed Web of Science ®Google Scholar
• Stone MJ, Hayward JA, Huang C, Sanchez J, Sanchez J. Mechanisms of regulation of the chemokine-receptor network. Int J Mol Sci. 2017;18(2):342. doi:10.3390/ijms18020342
   PubMed Web of Science ®Google Scholar
• Manoura A, Gourgiotis D, Galanakis E, et al. Circulating concentrations of alpha- and beta-chemokines in neonatal sepsis. Int J Infect Dis. 2010;14(9):e806–809. doi:10.1016/j.ijid.2010.03.015
   Web of Science ®Google Scholar
• Liew PX, Kubes P. The neutrophil’s role during health and disease. Physiol Rev. 2019;99(2):1223–1248. doi:10.1152/physrev.00012.2018
   PubMed Web of Science ®Google Scholar
• Ohlsson K, Olsson AS. Immunoreactive granulocyte elastase in human serum. Hoppe Seylers Z Physiol Chem. 1978;359(11):1531–1539. doi:10.1515/bchm2.1978.359.2.1531
   Google Scholar
• Shi Y, Li HQ, Shen CK, et al. Plasma nitric oxide levels in newborn infants with sepsis. J Pediatr. 1993;123(3):435–438. doi:10.1016/S0022-3476(05)81753-6
   Web of Science ®Google Scholar
• Wilson C, Kollmann T. Induction of antigen-specific immunity in human neonates and infants. In: The Window of Opportunity: Pre-Pregnancy to 24 Months of Age. Vol. 61. Karger Publishers; 2008:183–195.
   Google Scholar
• Roger T, Schneider A, Weier M, et al. High expression levels of macrophage migration inhibitory factor sustain the innate immune responses of neonates. Proc Natl Acad Sci U S A. 2016;113(8):E997–E1005. doi:10.1073/pnas.1514018113
   Web of Science ®Google Scholar
• Kang I, Bucala R. The immunobiology of MIF: function, genetics and prospects for precision medicine. Nat Rev Rheumatol. 2019;15(7):427–437. doi:10.1038/s41584-019-0238-2
   PubMed Web of Science ®Google Scholar
• Sparkes A, De Baetselier P, Brys L, et al. Novel half-life extended anti-MIF nanobodies protect against endotoxic shock. FASEB J. 2018;32(6):3411–3422. doi:10.1096/fj.201701189R
   PubMed Web of Science ®Google Scholar
• Li T, Sun H, Li Y, et al. Downregulation of macrophage migration inhibitory factor attenuates NLRP3 inflammasome mediated pyroptosis in sepsis-induced AKI. Cell Death Discov. 2022;8(1):61. doi:10.1038/s41420-022-00859-z
   Web of Science ®Google Scholar
• Bozza FA, Gomes RN, Japiassu AM, et al. Macrophage migration inhibitory factor levels correlate with fatal outcome in sepsis. Shock. 2004;22(4):309–313. doi:10.1097/01.shk.0000140305.01641.c8
   PubMed Web of Science ®Google Scholar
• Emonts M, Sweep FC, Grebenchtchikov N, et al. Association between high levels of blood macrophage migration inhibitory factor, inappropriate adrenal response, and early death in patients with severe sepsis. Clin Infect Dis. 2007;44(10):1321–1328. doi:10.1086/514344
   Web of Science ®Google Scholar
• He M, Moochhala SM, Adhikari S, Bhatia M. Administration of exogenous fractalkine, a CX3C chemokine, is capable of modulating inflammatory response in cecal ligation and puncture-induced sepsis. Shock. 2009;31(1):33–39. doi:10.1097/SHK.0b013e31817789da
   Web of Science ®Google Scholar
• Hoogendijk AJ, Wiewel MA, van Vught LA, et al. Plasma fractalkine is a sustained marker of disease severity and outcome in sepsis patients. Crit Care. 2015;19(1):412. doi:10.1186/s13054-015-1125-0
   Web of Science ®Google Scholar
• Ancuta P, Rao R, Moses A, et al. Fractalkine preferentially mediates arrest and migration of CD16+ monocytes. J Exp Med. 2003;197(12):1701–1707. doi:10.1084/jem.20022156
   PubMed Web of Science ®Google Scholar